Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation
Jeffery J. Auletta(Nationwide Children's Hospital), Frederick P. Heinzel(Louis Stokes Cleveland VA Medical Center), James L.M. Ferrara(Tisch Hospital), Jennifer DeVecchio(Louis Stokes Cleveland VA Medical Center)
Cited by 20
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458
A biomarker panel for acute graft-versus-host disease
|Blood|2008|404
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
|New England Journal of Medicine|2013|403